Core Viewpoint - The conference focused on the application of artificial intelligence in hospitals and the innovative directions for improving hospital operations through digital intelligence [1] Group 1: AI and Healthcare Integration - JD Health aims to systematically open its leading "super pharmaceutical supply chain" capabilities and medical AI products to build a safe, reliable, and efficient "new infrastructure for medical digital intelligence" [3] - The "JD Zhuoyi" 2.0 version, a large model product for hospital applications, has served over 5 million patients since its launch in 2025 [3] Group 2: Clinical Nutrition and AI - JD Health collaborated with Wenzhou Medical University First Affiliated Hospital to create a "clinical nutrition large model" that integrates over a million high-quality nutrition literature and real-world cases for precise clinical practice [4] - The AI-assisted tools in pharmaceutical management help focus on high-value diagnosis and build a closed-loop management system for prescriptions [4] Group 3: Weight Management Innovations - The "AI + weight management" model employs a "layered service + human-machine collaboration" approach, enhancing patient compliance through AI feedback and emotional support [4] Group 4: Strategic Collaborations - JD Health and Wenzhou Medical University First Affiliated Hospital released an AI-driven clinical nutrition management solution, providing a replicable model for high-quality development in clinical nutrition [5] - Strategic partnerships were formed with various brands to integrate quality nutrition products and supply chain services, facilitating personalized nutrition solutions [5]

Core Viewpoint - The article discusses the ongoing debate in the medical AI sector regarding whether AI can fully replace doctors or simply enhance their capabilities, highlighting the need for practical AI solutions that address real-world challenges in healthcare [2][3]. Group 1: Market Trends and Developments - The Hong Kong stock market has seen a surge in AI medical concepts since the beginning of the year, driven by various initiatives from major companies like Ant Group and Alibaba, which have heightened investor interest in the sector [2]. - A significant debate has emerged in the industry, particularly after Zhang Wenhong, director of the National Center for Infectious Disease Medicine, expressed his refusal to integrate AI into his hospital's electronic medical record system, reigniting discussions on AI's role in healthcare [2]. Group 2: Company Initiatives and Strategies - JD Health has positioned itself on the side of practical solutions, emphasizing the importance of AI that can genuinely alleviate burdens for healthcare providers and improve patient experiences [3][4]. - At the recent "Annual Doctor Ceremony" and "Smart Medical Conference," JD Health introduced "JD Zhuoyi 2.0" for hospitals and the AI tool "Zhi Yi" for doctors, establishing a dual empowerment matrix targeting both healthcare providers and institutions [4][6]. Group 3: AI Application and Solutions - JD Health's CEO, Cao Dong, articulated a focus on three core issues: reducing the workload for healthcare providers, enhancing diagnostic quality, and improving patient experiences through AI [6]. - The company has identified three major pain points in hospitals: clinical nutrition management, medication supply issues, and chronic disease management, which have informed the development of its "JD Zhuoyi 2.0" system [7][9]. Group 4: Specific Solutions Offered - The "JD Zhuoyi 2.0" system addresses clinical nutrition management by providing an AI-driven solution that streamlines the entire process from outpatient to inpatient care, significantly reducing patient hospital visits and improving nutritional management [10]. - For medication services, the system utilizes AI to manage prescription reviews and follow-ups, ensuring compliance and improving the efficiency of medication delivery [12]. - In weight management, the system identifies individuals needing intervention and offers personalized plans, aiming to cover 80% of high-risk patients through digital tracking and support [12]. Group 5: AI Product Development - The "Zhi Yi" product aims to serve as an intelligent assistant for doctors, integrating a vast database of medical literature and guidelines to enhance clinical decision-making and research capabilities [15][16]. - Recent tests have shown that "Zhi Yi" outperformed competitors in confidence levels and coverage of reference materials, addressing concerns about the accuracy of AI in medical applications [16]. Group 6: Long-term Vision and Market Positioning - JD Health's strategy emphasizes long-term investment and compliance, aiming to create a sustainable value proposition rather than chasing short-term gains [22]. - The company adopts a business model that combines free tools for doctors with value-added services and supply chain revenue, fostering a cycle of value creation and revenue sharing [22]. - The overarching goal is to integrate AI into hospital operations effectively, ensuring that it serves as a practical tool rather than an additional burden for healthcare providers [22].

Core Viewpoint - The article discusses the ongoing debate in the medical AI sector regarding whether AI can fully replace doctors or enhance their capabilities, highlighting the need for practical AI solutions that address real-world challenges in healthcare [2][3]. Group 1: AI in Healthcare Market Trends - The Hong Kong stock market has seen a surge in AI medical concepts since the beginning of the year, driven by significant updates from companies like Ant Group and Alibaba, which have heightened investor interest in the sector [2]. - There is a clear division in the industry, with some companies focusing on consumer-facing solutions while others target operational efficiencies within hospitals [2][3]. Group 2: JD Health's Approach - JD Health has positioned itself on the side of practical solutions, launching "JD Zhaoyi 2.0" aimed at empowering hospitals and doctors through AI tools [4][6]. - The CEO of JD Health emphasized that the focus should be on reducing the burden on healthcare providers, improving diagnostic quality, and enhancing patient experience [6]. Group 3: Identified Pain Points in Healthcare - JD Health's research identified three major challenges in hospitals: inadequate clinical nutrition management, issues with outpatient medication continuity, and difficulties in chronic disease management [9][11]. - The average incidence of nutritional risk among hospitalized patients is reported at 23.3%, with over 50% of cancer patients experiencing malnutrition [11]. Group 4: JD Zhaoyi 2.0 Solutions - JD Zhaoyi 2.0 offers three key solutions: clinical nutrition management, pharmaceutical services, and weight management, creating a comprehensive response to hospital challenges [12][15]. - The clinical nutrition solution aims to streamline processes and reduce costs by utilizing AI to manage patient nutrition from admission to discharge [13]. Group 5: AI Product "Zhi Yi" - The "Zhi Yi" product was introduced to assist doctors by integrating a vast database of medical literature and guidelines, aiming to enhance clinical decision-making and research efficiency [20][21]. - "Zhi Yi" has shown high performance in tests, particularly in confidence levels and coverage of reference materials, addressing concerns about the accuracy of AI in medical applications [21][22]. Group 6: Long-term Strategy and Market Positioning - JD Health's strategy focuses on long-term investment and compliance, aiming to create a sustainable value proposition rather than chasing short-term gains [28][29]. - The company employs a business model that combines free tools for doctors with value-added services and supply chain revenue, fostering a cycle of value creation and revenue sharing [28][29].

Core Viewpoint - JD Health has officially launched the 2.0 version of its large model product "JD Zhuoyi," which integrates AI and supply chain capabilities to provide comprehensive management solutions for hospitals [1][3]. Group 1: Product Features - The new JD Zhuoyi 2.0 combines JD Health's "AI + Supply Chain" advantages, creating a system that supports clinical nutrition, outpatient medication, and weight management [1][3]. - The "AI + Clinical Nutrition" feature focuses on nutritional assessment and intervention for inpatients and outpatients, making nutritional treatment traceable and assessable [1][3]. - A "Clinical Nutrition Large Model" developed in collaboration with Wenzhou Medical University and the National Health Commission provides foundational support for the solution, enabling automatic assistance for healthcare personnel in nutrition risk screening, assessment, diagnosis, and personalized treatment plan generation [1][3]. Group 2: AI Applications - The "AI + Pharmacy Management" feature utilizes AI tools for prescription review and smart pharmacist assistance, allowing doctors and pharmacists to focus on high-value diagnosis and academic development [2][4]. - An AI prescription flow platform has been established to manage the entire cycle of prescription review, medication collection, home medication, and follow-up prescriptions, with 24/7 online AI pharmacists available for patient inquiries [2][4]. - The "AI + Weight Management" feature automates standard tasks, allowing professional doctors to concentrate on critical decisions and risk management, balancing scalable services with cost control [2][4]. Group 3: Patient Engagement - The solution integrates hospital medical data with external lifestyle data to create a complete patient profile, using AI to recommend effective weight treatment plans [2][4]. - AI provides instant feedback and emotional support, converting medical advice into daily actionable tasks, enhancing patient compliance through encouragement and guidance after completing dietary, exercise, and weight tracking [2][4].

Group 1 - The core viewpoint of the articles highlights the launch of an AI-driven clinical nutrition management solution by JD Health in collaboration with Wenzhou Medical University First Affiliated Hospital and the National Health Commission's Clinical Nutrition and Intervention Key Laboratory, aimed at improving medical quality and patient outcomes under the "Healthy China 2030" strategy [2] - The solution encompasses seven key stages of patient care, including screening, assessment, diagnosis, treatment, control, management, and education, establishing an integrated management system of "system—formulation—quality control" [2] - The technical core of the solution is the "Clinical Nutrition Large Model," developed collaboratively, which utilizes JD Health's proprietary medical model "JD Medical Qianxun" and has been trained on over one million nutrition-related literature and tens of thousands of real clinical cases [2] Group 2 - JD Health's "JD Zhuoyi 2.0" model, an integral part of its full-scenario large model product, can be embedded into existing hospital systems, facilitating a closed-loop from in-hospital diagnosis to out-of-hospital continuous management [3] - The collaboration with Wenzhou Medical University First Affiliated Hospital has already served over 4.7 million patients through the "Clinical Nutrition + Special Medical Food" service network, indicating the model's scalability for nationwide promotion [3] - JD Health's CEO, Cao Dong, emphasized the company's commitment to opening its leading "super pharmaceutical supply chain" capabilities and medical AI products to a broader range of partners, aiming to build a safe, reliable, and efficient "new infrastructure for medical digitization" [3]

Core Insights - The conference focused on the application of artificial intelligence (AI) in hospitals and the innovative directions for enhancing hospital operations through digital intelligence [1][8] - JD Health launched the 2.0 version of its "JD Zhuoyi" product, aimed at becoming a new growth engine for hospitals, having already served over 5 million patients since its initial launch in 2025 [2][3] Group 1: Product Launch and Features - JD Zhuoyi 2.0 integrates JD Health's "AI + Supply Chain" capabilities, providing a comprehensive management solution covering clinical nutrition, outpatient medication, and weight management [2][4] - The "AI + Clinical Nutrition" model focuses on nutritional assessment and intervention, utilizing a clinical nutrition model supported by extensive literature and real-world cases to enhance patient outcomes [3][4] - The "AI + Pharmacy Management" model aims to streamline the medication process through AI-assisted prescription review and a 24/7 online AI pharmacist, improving patient adherence and satisfaction [4] Group 2: Industry Collaboration and Insights - The conference featured discussions from various hospital leaders on the practical experiences and innovative measures in AI-enabled healthcare, contributing diverse perspectives to industry development [5][6] - JD Health signed strategic cooperation agreements with multiple partners to enhance the application of AI in healthcare, aiming to create a comprehensive supply chain for personalized nutrition solutions [7] - The successful hosting of the conference highlighted JD Health's technological strength in the medical AI field and established a platform for industry collaboration [8]